COMMUNIQUÉS West-GlobeNewswire

Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
30/01/2019
Fexinidazole will contribute to international efforts to eliminate sleeping sickness, a fatal neglected tropical disease endemic to Africa, by 2020 It is the first all-oral treatment for sleeping sickness, and is [...]
Sanofi : Le fexinidazole, premier traitement entièrement par voie orale contre la maladie du sommeil, approuvé en République Démocratique du Congo
30/01/2019
Le fexinidazole contribuera aux efforts déployés à l'échelle internationale en vue d'éliminer la maladie du sommeil - une maladie tropicale négligée, fatale et endémique en Afrique - à l'horizon 2020 Premier médicament [...]
Imprivata to Showcase Purpose-built Solutions for Healthcare at 2019 HIMSS Annual Conference
30/01/2019
Imprivata streamlines clinical workflows by offering ubiquitous access and multifactor authentication solutions LEXINGTON, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, will [...]
CherryCircle Software Raises $2.3M to Advance QbDVision™ for Pharmaceutical Industry
30/01/2019
AUSTIN, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- CherryCircle Software, a company developing novel solutions for pharmaceutical process development, announced the closing of a $2.3 million Seed financing round. The [...]
Relievant Announces Level I INTRACEPT Study Enrollment Stopped Early for Superiority
30/01/2019
Intracept ® Procedure Demonstrates Highly Significant Treatment Effect vs. Non-Surgical Management MINNEAPOLIS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company, developing [...]
NewLink Genetics to Participate in the Immuno-Oncology 360° Conference
30/01/2019
AMES, Iowa, Jan. 30, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company’s Chairman, CEO and Chief Scientific Officer, Charles J. Link, Jr, MD, will participate in the [...]
Konica Minolta Healthcare Releases Software Upgrade for SONIMAGE® HS1 Ultrasound System Featuring Improvements in Clinical Workflow and MSK Functionality
30/01/2019
WAYNE, N.J., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a developer of high-end, point-of-care ultrasound solutions, announces the release of a new software upgrade for the SONIMAGE® HS1 [...]
Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019
30/01/2019
Results to be presented on Thursday, February 7, 2019 at 11:36 a.m. HST/4:36 p.m. EST SOUTH SAN FRANCISCO, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that [...]
Medtronic Announces Positive Results from the Largest ENB Study to Aid in Lung Cancer Diagnosis, Staging, and Treatment Preparation in a Single Minimally Invasive Procedure
30/01/2019
Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum Medtronic Initiates Separate Study to Evaluate the Safety and Performance of the Emprint(TM) Ablation Catheter with the [...]
Corvus Pharmaceuticals to Present Updated Biomarker and Clinical Data on Lead Development Programs CPI-444 and CPI-006 at Immuno-Oncology 360° Conference
30/01/2019
BURLINGAME, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2018 Results
30/01/2019
BRISBANE, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, will announce [...]
Assure Holdings Continues Expansion with New Partnership in Louisiana
30/01/2019
New Partnership Brings Two Additional Surgeons to Assure’s Platform DENVER, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative [...]
Kane Biotech Expands Previously-Announced Single Largest Order of bluestem™ Products
30/01/2019
Major Retailer Orders Additional Inventory in Anticipation of High Demand WINNIPEG, Manitoba, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), is [...]
IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT® NDA
30/01/2019
SAINT LAURENT, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the U.S. Food and Drug Administration (“FDA”) [...]
Neos Therapeutics Announces Appointment of James Robinson to Board of Directors
30/01/2019
DALLAS and FORT WORTH, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET
30/01/2019
WALTHAM, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2018 financial results will be released on Thursday, February 7, 2019 [...]
CytomX Therapeutics to Host Research and Development Day on February 26, 2019
30/01/2019
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
BioTime Inc. Affiliate Company OncoCyte Corporation Reports Successful Results With DetermaVu™ Diagnostic Test for Lung Cancer
30/01/2019
ALAMEDA, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its affiliate company, OncoCyte [...]
Aduro Biotech Announces Strategic Reset
30/01/2019
BERKELEY, Calif., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced a strategic reset to focus on Aduro’s core strengths – discovery and development of novel product candidates in the [...]

Pages